Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people starting Wegovy notice their skin feels more reactive than usual — patches of redness, unusual tenderness at the injection site, or a general sensitivity they hadn't expected. These responses are real, they're reported by patients, and they deserve a straight answer. Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management, and like any prescription medicine it can affect the body in ways that go beyond appetite alone. This page explains what the evidence says about semaglutide and skin sensitivity, what tends to settle on its own, and what's worth mentioning to a prescriber. Because Wegovy is a prescription-only medicine, any decision about whether it's suitable for you (and how to manage side effects) belongs with a qualified clinician, not a search engine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you're a few weeks into treatment, the nausea has started to ease, and then you notice something odd. The skin around your injection site is red and slightly puffy after your dose. Or maybe it's not even the injection spot — your face feels more sensitive in sunlight, your arms itch, or products you've used for years suddenly seem irritating. You're not imagining it, and you're not alone in noticing it.
Injection-site reactions are the most consistently reported skin effect in the Wegovy clinical programme. In the STEP 1 trial, which followed adults with obesity over 68 weeks, these reactions (redness, swelling, bruising, itching at the injection point) were recorded as adverse events in a meaningful proportion of participants. The NHS semaglutide medicines page lists injection-site reactions explicitly among common side effects, placing them in the same category as the better-known gastrointestinal ones.
The practical fix for most injection-site responses is technique. Rotating your injection site every week (between abdomen, thigh and upper arm) stops the same patch of skin from bearing all the load. Letting the pen reach room temperature before injecting reduces the sting. Keeping the area clean but not over-scrubbed helps too. A quick self-check worth building into your weekly routine: before you inject, scan last week's spot for any lingering tenderness or raised skin, and simply move a couple of inches away. That one habit, under a minute, makes a real difference over months of treatment.
The broader question (does semaglutide cause skin sensitivity across the body, not just at the needle site) is harder to answer with the same confidence. Anecdotal reports exist, and some patients describe a heightened sensitivity to sunlight or touch that they associate with starting treatment. If you've come across these accounts, our pages on sun sensitivity with Wegovy and light sensitivity during semaglutide treatment cover those specific patterns in more detail.
What we can say from the biology: semaglutide slows gastric emptying, which changes the rate at which things move through your system. This doesn't directly make skin more reactive, but it does mean the body is processing things differently. Separately, the weight loss itself changes skin physiology over time, as fat redistributes and the body adapts, some people report changes in skin texture, dryness, or sensitivity that are more about the metabolic shift than the medicine directly. These are not the same as an allergic reaction.
A true allergic response to semaglutide (anaphylaxis or severe hypersensitivity) is listed as a rare but serious event. Signs include swelling of the face, lips, tongue or throat, difficulty breathing, rapid heartbeat, or a widespread rash appearing shortly after injection. If any of those happen, call 999 immediately. This is categorically different from the localised redness most people experience.
Because semaglutide alters how quickly things move through the gut, there's a practical implication for medicines taken by mouth. For people using both Wegovy and topical treatments that have an oral component (or switching between the injection and the newer oral semaglutide tablet form) the absorption question is worth raising with a prescriber. This is especially relevant for women using oral contraceptives alongside tirzepatide (a related GLP-1 medicine); NHS guidance on weight management injections covers contraception considerations in detail, and the principle of discussing all medications with your prescriber applies equally here.
For skincare specifically, the evidence doesn't point to semaglutide making the skin barrier itself more permeable. But if you find your skin is reacting to products it previously tolerated, the simplest starting point is stripping your routine back to basics (unfragranced cleanser and moisturiser) to identify whether the culprit is the medicine, the weight-loss process, or something in your current products. Some people also notice changes in how their skin smells or feels during treatment, which the page on smell sensitivity with semaglutide explores. Reporting unexpected skin effects to the MHRA via the Yellow Card scheme contributes to ongoing safety monitoring for medicines like Wegovy, which still carries a Black Triangle (▼) status in the UK, meaning it's subject to additional surveillance.
Most injection-site reactions settle within a few days and don't require stopping treatment. Persistent redness lasting more than a week, spreading redness, warmth and pain that suggests an infection rather than irritation, or a rash appearing at a distance from the injection point, these are all worth flagging to your prescriber sooner rather than later. Don't adjust your dose or stop treatment without speaking to a clinician first.
If you're considering starting Wegovy and you have a history of skin conditions, eczema, or known drug sensitivities, that's precisely the kind of context a prescriber needs to know about at the consultation stage. The same applies to anyone wondering whether Wegovy might interact with other treatments they're using. At nume, every consultation is read by a GPhC-registered prescriber who can weigh your full picture; if you'd like that review, you can start your free consultation with our clinical team. Understanding what Wegovy costs as part of that private route is covered on our Wegovy cost page if that's useful context. More information about the treatment options available through our pharmacy is on the weight loss treatments overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.